Results 61 to 70 of about 1,666,748 (304)

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders : results from the European Network of Rare Bleeding Disorders

, 2012
: Background: The European Network of Rare Bleeding Disorders (EN-RBD) was established to bridge the gap between knowledge and practise in the care of patients with RBDs.
Peyvandi, F., Palla, R., Menegatti, M., et al., Gadisseur, Alain   +4 more
core  

Ageing and women with bleeding disorders

, 2022
As life expectancy increases, women with bleeding disorders can expect to live for decades after their menopause – potentially with a range of comorbidities including cardiovascular (CV) disease, cancer and osteoporosis.
d’Oiron Roseline, Radhakrishnan Sheila
core   +1 more source

Diffuse MRI Edema Predicts Relapse in Cerebral Amyloid Angiopathy–Related Inflammation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To identify MRI predictors of relapse and quantify relapse and mortality risk in cerebral amyloid angiopathy–related inflammation (CAA‐RI). A secondary objective was to assess the association between mycophenolate mofetil use and relapse risk. Methods We performed a retrospective cohort study of 36 patients with CAA‐RI treated at the
G. Abbas Kharal, Gowtham Yerneni, Kim J. Griffin, Nicolas Thompson, Ken Uchino, Irene Katzan, Dolora Wisco, Abeer Farrag, Jayashree Sundarajan, Andrew Russman, M. Shazam Hussain   +10 more
wiley   +1 more source

Rare congenital bleeding disorders

, 2018
The rare congenital bleeding disorders are a heterogeneous group of diseases which include deficiencies of fibrinogen, prothrombin and factors V, V + VIII, VII, X, XI and XIII.
Franchini, Massimo, Vaglio, Stefania, Pati, Ilaria, Veropalumbo, Eva, Piccinini, Vanessa, Masiello, Francesca, Marano, Giuseppe, Catalano, Liviana, Pupella, Simonetta, Liumbruno, Giancarlo Maria   +9 more
core   +1 more source

Evaluation for Bleeding Disorders in Suspected Child Abuse.

, 2022
Bruising or bleeding in a child can raise the concern for child abuse. Assessing whether the findings are the result of trauma and/or whether the child has a bleeding disorder is critical.
Graham, Doug, Legano, Lori A, Messner, Stephen A, Rogers, Zora R, Hijiya, Nobuko, Warwick, Anne, AAP SECTION ON HEMATOLOGY/ONCOLOGY, THE AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY, THE AAP COUNCIL ON CHILD ABUSE AND NEGLECT, Idzerda, Sheila M, Council on Child Abuse and Neglect, 2020–2021, Matjasko, Jennifer, Hooker, Ryan, Wilson, Hope, Nienow, Shalon Marie, Mendonca, Eneida A, Edward, Heather, Gilmartin, Amanda Bird Hoffert, Stork, Linda, Carpenter, Shannon L, Downs, Stephen M, Sirotnak, Andrew P, American Academy of Child and Adolescent Psychiatry, Anderst, James, Jain, Juhi, Haney, Suzanne B, Lipton, Jeffrey, Pace, Betty, Council on Child Abuse and Neglect executive committee members, Section on Hematology/Oncology executive committee, 2020–2021, Allen, Carl, Billett, Amy, Dickens, David, Centers for Disease Control and Prevention, Di Paola, Jorge, Velez, Maria C, Wetmore, Cynthia, Yates, Amber, Keeshin, Brooks, Girardet, Rebecca Greenlee, Heavilin, Nancy, Kirkwood, Suzanne, Abshire, Thomas C, Raj, Anish, Laskey, Antoinette, Rosado, Norell, Hastings, Caroline, Matthews, Dana, Council on Foster Care, Adoption and Kinship Care, Forkey, Heather C, Chavdar, Müge, Killough, Emily, Gavril, Amy R, Mohr, Bethany Anne, American Society of Pediatric Hematology/Oncology Board of Trustees, 2020–2021, Harper, James, Leavey, Patrick, Hord, Jeffrey, Asnes, Andrea Gottsegen, Wechsler, Dan   +57 more
core   +1 more source

Safety of Prescription Nonsteroidal Anti‐inflammatory Drugs in Adults With Inflammatory Bowel Disease: Data From a Large Administrative Claims Cohort

Arthritis Care &Research, EarlyView.
Objective The concern that nonsteroidal anti‐inflammatory drugs (NSAIDs) may precipitate flares of inflammatory bowel disease (IBD) has limited their use in managing musculoskeletal symptoms in those with IBD, but safety data are mixed. Methods This retrospective cohort study included patients with IBD aged at least 18 years from Optum's deidentified ...
Adam S. Mayer, Rui Xiao, Meenakshi Bewtra, Michael D. George, Pamela F. Weiss   +4 more
wiley   +1 more source

Safety, efficacy, and treatment satisfaction in adults with ITP who switched to avatrombopag from another TPO-RA

Blood Advances
: This phase 4, multicenter, open-label study was conducted to evaluate the safety, efficacy, and treatment satisfaction of switching to avatrombopag from another thrombopoietin receptor agonist (TPO-RA) in patients with immune thrombocytopenia (ITP ...
Michael D. Tarantino, Kailash Mosalpuria, Scott Kolodny, Jessica Zhang, Michael Vredenburg, Brian D. Jamieson   +5 more
doaj   +1 more source

Inherited bleeding disorders [PDF]

, 2018
Abnormal bleeding is a common clinical presentation in general practice, and a rational  approach to this problem is therefore required. Investigation of a suspected bleeding disorder necessitates a comprehensive history, thorough physical examination ...
Louw, S., Alli, N., Vaughan, J., Mahlangu, J., Schapkaitz, E.   +4 more
core  

Pharmacokinetics of extended half-life albumin-fused factor IX and heterogeneous F9 variants in hemophilia B: a retrospective cohort study

Bleeding, Thrombosis and Vascular Biology
No information is available about the influence exerted by F9 variants on extended half-life (EHL)-recombinant factor IX (rFIX) pharmacokinetics (PK). Adult patients with severe HB (n=41), infused with EHL albumin-fused-rIX-FP, were investigated for key
Barbara Lunghi, Massimo Morfini, Silvia Linari, Dario Balestra, Alessio Branchini, Lisa Pieri, Donata Belvini, Laura Banov, Cristina Santoro, Giancarlo Castaman, Francesco Bernardi   +10 more
doaj   +1 more source

The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia

Haematologica, 2015
Standard treatment for Glanzmann thrombasthenia is platelet transfusion. Recombinant activated factor VII has been shown to be successful in patients with Glanzmann thrombasthenia with platelet antibodies or who are refractory to platelet transfusions ...
Giovanni Di Minno, Rainer B Zotz, Roseline d’Oiron, Niels Bindslev, Matteo Nicola Dario Di Minno, Man-Chiu Poon   +5 more
doaj   +1 more source